An Exceedingly Rare Case of Liraglutide-Induced Liver Injury
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Case Reports in Gastrointestinal Medicine |
| Online Access: | http://dx.doi.org/10.1155/2021/6306149 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832565222562332672 |
|---|---|
| author | Swetha Parvataneni Rajarajeshwari Ramachandran Eric Then Tyler Grantham Vinaya Gaduputi |
| author_facet | Swetha Parvataneni Rajarajeshwari Ramachandran Eric Then Tyler Grantham Vinaya Gaduputi |
| author_sort | Swetha Parvataneni |
| collection | DOAJ |
| description | Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug. |
| format | Article |
| id | doaj-art-373a093bca2e45989d0e9b57e9c3d514 |
| institution | Kabale University |
| issn | 2090-6528 2090-6536 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Gastrointestinal Medicine |
| spelling | doaj-art-373a093bca2e45989d0e9b57e9c3d5142025-02-03T01:08:51ZengWileyCase Reports in Gastrointestinal Medicine2090-65282090-65362021-01-01202110.1155/2021/63061496306149An Exceedingly Rare Case of Liraglutide-Induced Liver InjurySwetha Parvataneni0Rajarajeshwari Ramachandran1Eric Then2Tyler Grantham3Vinaya Gaduputi4Department of Internal Medicine, Geisinger Lewistown Hospital, Lewiston, Pennsylvania, USADepartment of Gastroenterology, Brooklyn Hospital Center, Brooklyn, New York, USADepartment of Gastroenterology, Brooklyn Hospital Center, Brooklyn, New York, USASt. George’s University, St. George, GrenadaDepartment of Gastroenterology, Blanchard Valley Health System, Findlay, Ohio, USALiraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.http://dx.doi.org/10.1155/2021/6306149 |
| spellingShingle | Swetha Parvataneni Rajarajeshwari Ramachandran Eric Then Tyler Grantham Vinaya Gaduputi An Exceedingly Rare Case of Liraglutide-Induced Liver Injury Case Reports in Gastrointestinal Medicine |
| title | An Exceedingly Rare Case of Liraglutide-Induced Liver Injury |
| title_full | An Exceedingly Rare Case of Liraglutide-Induced Liver Injury |
| title_fullStr | An Exceedingly Rare Case of Liraglutide-Induced Liver Injury |
| title_full_unstemmed | An Exceedingly Rare Case of Liraglutide-Induced Liver Injury |
| title_short | An Exceedingly Rare Case of Liraglutide-Induced Liver Injury |
| title_sort | exceedingly rare case of liraglutide induced liver injury |
| url | http://dx.doi.org/10.1155/2021/6306149 |
| work_keys_str_mv | AT swethaparvataneni anexceedinglyrarecaseofliraglutideinducedliverinjury AT rajarajeshwariramachandran anexceedinglyrarecaseofliraglutideinducedliverinjury AT ericthen anexceedinglyrarecaseofliraglutideinducedliverinjury AT tylergrantham anexceedinglyrarecaseofliraglutideinducedliverinjury AT vinayagaduputi anexceedinglyrarecaseofliraglutideinducedliverinjury AT swethaparvataneni exceedinglyrarecaseofliraglutideinducedliverinjury AT rajarajeshwariramachandran exceedinglyrarecaseofliraglutideinducedliverinjury AT ericthen exceedinglyrarecaseofliraglutideinducedliverinjury AT tylergrantham exceedinglyrarecaseofliraglutideinducedliverinjury AT vinayagaduputi exceedinglyrarecaseofliraglutideinducedliverinjury |